Clinical Trial Update: Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Elucirem for DSC-MRI perfusion in brain gliomas has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Glioma
• Brain Tumor

Drugs mentioned

• Elucirem

Snippet

Sponsor: Guerbet | Conditions: Brain Tumor, Primary, Brain Tumor, Recurrent | Phase 3 | Status: COMPLETED | Results posted: 2026-01-29